Latest Articles

Publication Date
The value of the AAGL staging system for predicting recurrence after conservative surgery for ovarian endometriomas.

Ovarian endometrioma (OMA) is the most prevalent form of endometriosis. Conservative surgical management of the condition is associated with a relatively high recurrence rate, the degree of which is potentially …

Published: Jan. 5, 2026, midnight
Investigating the role of artificial intelligence in the diagnosis and prediction of endometriosis using ultrasound images: a systematic review.

Published: Jan. 3, 2026, midnight
Endometrial immune profile: A predictor of pregnancy success.

The likelihood of a successful pregnancy is influenced by a set of variables that influence endometrial receptivity, including hormonal, genetic, metabolic, age, lifestyle, and immunological factors. Among these, the endometrial …

Published: Dec. 31, 2025, midnight
[Analysis of body composition in infertile patients with endometriosis complicated with endometrial polyps].

Objective: To investigate the risk factors of endometrial polyps (EP) in patients with endometriosis (EM) and to analyze the predictive value of body composition measurement for EP. Methods: From January …

Published: Dec. 30, 2025, midnight
Vascular graph network for ovarian lesion classification using optical-resolution photoacoustic microscopy.

Diagnosing ovarian lesions is challenging because of their heterogeneous clinical presentations. Some benign ovarian conditions, such as endometriosis, can have features that mimic cancer. We use optical-resolution photoacoustic microscopy (OR-PAM) …

Published: Dec. 30, 2025, midnight
Predictive value of MR imaging IVIM and T2 mapping in malignant transformation of endometriosis.

This study aims to explore the value of MRI intravoxel incoherent motion (IVIM) combined with T2 mapping in predicting the malignancy of endometriosis (EM) and construct a noninvasive preoperative risk …

Published: Dec. 24, 2025, midnight
Pharmacokinetic-Pharmacodynamic Modeling and Simulation of Merigolix, a Nonpeptide Gonadotropin-Releasing Hormone Antagonist.

Gonadotropin-releasing hormone (GnRH) antagonists inhibit estrogen synthesis and secretion, making them promising treatment options for estrogen-dependent diseases, such as endometriosis. This study developed a population pharmacokinetic/pharmacodynamic (PK/PD) model for merigolix, …

Published: Dec. 20, 2025, midnight
Non-Invasive Diagnosis of Endometriosis by Questionnaires in Patients Using Contraception.

Background/Objectives: The assessment of endometriosis (EMS)-associated pain is important, but only very few studies address the potential use of questionnaires for non-invasive prediction of the disease. Methods: In a prospective …

Published: Dec. 20, 2025, midnight
Prediction of MBS Item Codes for Endometriosis Surgery Using Transvaginal Ultrasound.

In March 2022, updates in the Australian Medicare Benefits Schedule relating to endometriosis surgery were made relating to item numbers 35637, 35631 and 35632 (division of 35638) and 35641. Updated …

Published: Dec. 19, 2025, midnight
EGR1 promotes ferroptosis in endometriosis through transcriptional activation of HMOX1.

Endometriosis (EM) affects approximately 10% of women of reproductive age and remains a prevalent estrogen-dependent gynecological disorder with limited therapeutic efficacy and high recurrence rates. Ferroptosis-an iron-dependent, non-apoptotic form of …

Published: Dec. 19, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!